-
Speeches in 2025 express exuberance for change and concern over same
Speakers emphasized technology‑neutral and principles‑based regulation, teased on new policies to come, or raised red flags.
-
Dana-Farber Cancer Institute pays $15m to resolve false claims charges
The case was exposed by an independent sleuth who used AI to uncover fraudulent, manipulated, and duplicated images.
-
A transformational 2025 in US healthcare – and more to come in 2026
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
-
What we learned from the DOJ’s year in enforcement
A new direction of travel has become clearer, which makes anticipating what happens next easier.
-
FDA turns focus on biologics in spate of warning letters
The three letters point to an enforcement posture toward manufacturers marketing biologics derived from human placentas and umbilical cords.
-
GRIP Extra: Treasury mulls stronger role for FinCEN, ESMA publishes supervisory expectations
Our in-brief roundup of notable stories from the last week.
-
Illinois men face charges for $300m healthcare fraud scheme
The brothers allegedly tried to defraud Medicare, Medicaid, and private insurers by filing claims for COVID-19 testing that was never given.
-
Georgia man sentenced to 46 months in prison for Medicare fraud
Patrick C Moore targeted Medicare beneficiaries to accept genetic tests that were not medically necessary or eligible for reimbursement.